Literature DB >> 8220249

Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation.

J A Simpson1, S E Smith, R T Dean.   

Abstract

We sought an explanation for the accumulation, and apparent poor degradation by alveolar phagocytes, of alginate in cystic fibrosis lung. A crude intracellular lyase preparation extracted from Klebsiella pneumoniae was able to degrade seaweed alginic acid as well as forms purified from Pseudomonas aeruginosa bacteria from Cystic Fibrosis (CF) patient lungs. This was by a beta-eliminative mechanism, as detected by an increase in the 232nm absorbance and activity was enhanced by deacetylation of the Pseudomonas aeruginosa alginates. Conditioned media or cell lysates from unstimulated or triggered phagocytic cells (including resident mouse peritoneal macrophages and the human macrophage cell line U937) had no effect in the same system. Free radicals generated by chemical systems or by gamma irradiation of water degraded alginate. Depolymerisation by free radicals, as detected by viscosity determinations and polyacrylamide gel electrophoresis, generated a wide range of fragment sizes. In contrast, mouse peritoneal macrophages or human polymorphonuclear neutrophils stimulated to generate free radicals had no significant effect on alginate. Under the conditions of our experiments, phagocytic cells representative of the CF lung are not able to degrade Pseudomonas aeruginosa alginate. This may explain the gross accumulation of alginate in CF lung.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220249

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  13 in total

1.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Involvement of stress-related genes polB and PA14_46880 in biofilm formation of Pseudomonas aeruginosa.

Authors:  Sahar A Alshalchi; Gregory G Anderson
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 3.  Pseudomonas biofilm matrix composition and niche biology.

Authors:  Ethan E Mann; Daniel J Wozniak
Journal:  FEMS Microbiol Rev       Date:  2012-01-23       Impact factor: 16.408

4.  The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis.

Authors:  Stephen E Lizewski; Derek S Lundberg; Michael J Schurr
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  The NtrC family regulator AlgB, which controls alginate biosynthesis in mucoid Pseudomonas aeruginosa, binds directly to the algD promoter.

Authors:  Andrew J Leech; April Sprinkle; Lynn Wood; Daniel J Wozniak; Dennis E Ohman
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

6.  Identification of AlgR-regulated genes in Pseudomonas aeruginosa by use of microarray analysis.

Authors:  Stephen E Lizewski; Jill R Schurr; Debra W Jackson; Anders Frisk; Alexander J Carterson; Michael J Schurr
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

Review 7.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

8.  Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia.

Authors:  Cristina Cigana; Nicola Ivan Lorè; Maria Lina Bernardini; Alessandra Bragonzi
Journal:  J Biomed Biotechnol       Date:  2011-07-14

9.  Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity.

Authors:  John W Lamppa; Margaret E Ackerman; Jennifer I Lai; Thomas C Scanlon; Karl E Griswold
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

Review 10.  Biofilm matrix and its regulation in Pseudomonas aeruginosa.

Authors:  Qing Wei; Luyan Z Ma
Journal:  Int J Mol Sci       Date:  2013-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.